Single-chain insulin

Details for Australian Patent Application No. 2004295023 (hide)

Owner Novo Nordisk A/S

Inventors Andersen, Asser Sloth; Sorensen, Anders Robert; Schlein, Morten; Kjeldsen, Thomas Borglum; Madsen, Peter

Agent Shelston IP

Pub. Number AU-A-2004295023

PCT Pub. Number WO2005/054291

Priority PA 2003 01786 03.12.03 DK

Filing date 3 December 2004

Wipo publication date 16 June 2005

International Classifications

C07K 14/62 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054291 Priority application(s): WO2005/054291

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295029-Antidiabetic compounds comprising benzofuran and benzothiophene derivatives

2004295022-Hydroxamic acid esters and pharmaceutical use thereof